US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Feb 13, 2026 (7 months ago)

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

What was recalled

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 84385-106-05Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China.

Recalling firm
Harbin Jixianglong Biotech Co., Ltd.
NDC code
84385-106-01
Origin
N/A, China
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0380-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all